Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00957086
PHASE3

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

Sponsor: National Cancer Centre, Singapore

View on ClinicalTrials.gov

Summary

The aim of the study is to improve the loco-regional control rate and overall survival of locally advanced head and neck squamous carcinoma (HNSCC). The investigators hypothesize that the addition of nimotuzumab (a recombinant humanized murine immune antibody that blocks both epidermal growth factor (EGF) and transforming growth factor (TGF)) to the current gold standard of concurrent chemoradiotherapy (CCRT) (7)(8), an adjuvant setting in patients after resection of their locally advanced HNSCC will confer therapeutic advantage.

Official title: Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head & Neck Squamous Cell Cancer

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

422

Start Date

2009-08-13

Completion Date

2026-03-11

Last Updated

2026-11-20

Healthy Volunteers

No

Interventions

DRUG

Nimotuzumab

Administered by intravenous infusion at 200 mg absolute per dose, diluted in 250 ml of sodium chloride over 30 minutes. 8 weekly doses of study drug will be given, beginning on first week of radiotherapy.

DRUG

Placebo

Administered by intravenous infusion at 200 mg absolute per dose, diluted in 250 ml of sodium chloride over 30 minutes. 8 weekly doses of study drug will be given, beginning on first week of radiotherapy.

Locations (30)

Flinders Medical Centre

Bedford Park, Australia

Peter MacCallum Cancer Centre

Melbourne, Australia

National Institute of Oncology and Radiobiology

Vedado, Cuba

Alexandria University School of Medicine

Alexandria, Egypt

National Cancer Institute, Cairo University

Cairo, Egypt

Apollo Hospital Bangalore

Bangalore, India

Narayana Hrudayalaya Hospital (Mazumdar Shaw Cancer Institute)

Bangalore, India

Amrita Institute of Medical Sciences

Kerala, India

Tata Memorial Centre

Mumbai, India

Christian Medical College

Tamil Nadu, India

Regional Cancer Center Trivandrum, India

Trivandrum, India

Cipto Mangunkusumo General Hospital Indonesia

Jakarta, Indonesia

Pantai Medical Centre, Kuala Lumpur

Kuala Lumpur, Malaysia

Mahkota Medical Center

Malacca, Malaysia

University of Santo Tomas Hospital

Manila, Philippines

St. Luke's Medical Center

Quezon City, Philippines

King Fahad Medical City

Riyadh, Saudi Arabia

National Cancer Centre

Singapore, Singapore

The Oncology Centre

Durban, South Africa

GVI Oncology

Panorama, South Africa

National Cancer Center Korea

Gyeonggi-do, South Korea

INHA University Hospital

Incheon, South Korea

Samsung Medical Center

Seoul, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

China Medical University Hospital

Taichung, Taiwan

Taipei Med Univ Hosp [TMUH]

Taipei, Taiwan

Taipei Veteran General Hospital

Taipei, Taiwan

National Cancer Institute Bangkok (+Chulabhorn for RT)

Bangkok, Thailand

Siriraj Hospital

Bangkok, Thailand

Chiang Mai Hospital

Chiang Mai, Thailand